FDA authorizes first pediatric COVID-19 vaccine; CDC to consider subsequent week

The meals and Drug Administration these days licensed Pfizer's COVID-19 vaccine for pediatric use, relocating the challenge of administration to the centers for ailment control and Prevention for consideration. FDA's authorization of the Pfizer vaccine, which is for babies a long time 5-11, heeds the advice of its independent advisory committee, made prior this week. The CDC's personal independent advisers meet Nov. 2 to believe the accessible records, after which the company's director will should formally sign off before the vaccine can also be administered to that age group.